Search

everythinglearnresearchcommunity

for

Search:↓

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

Apremilast may be a promising long-term treatment for hidradenitis suppurativa.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

The treatment with Shunyou and prednisone is effective and safe for lupus nephritis.

Adalimumab improved folliculitis decalvans in most patients.

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.

Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Fish oil increased cell growth and macrophages in the skin but didn't affect COX-2 expression.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

The new gel effectively treats psoriasis with minimal side effects.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Infliximab may cause hair loss in Crohn's disease patients.

Upadacitinib may effectively treat resistant lichen planopilaris.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

Immunological treatment improved both neuropathy and alopecia.

Semaglutide may help some skin disorders but can also cause skin issues.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.